This target was approved using a streamlined target validation route exclusive to small and medium-sized enterprises (SMEs). https://docs.sbtiservices.com/resources/FAQsforSMEs.pdf Medical Review Co.,Ltd commits to maintain zero scope 1 emissions through FY2030. Medical Review Co.,Ltd also commits to reduce absolute scope 2 GHG emissions 42% by FY2030 from a FY2024 base year, and to measure and reduce its scope 3 emissions.